Long-term Efficacy and Safety of Renal Denervation: Another Brick for Building a Hybrid Therapy for Hypertension?

Overview

Journal EuroIntervention

Specialties Cardiology & Vascular Diseases
Pharmacology

Date 2022 Oct 7

PMID 36205732

Authors

Massimo Volpe

Giovanna Gallo

Affiliations

Soon will be listed here.

References

Volpe M, Gallo G, Battistoni A, Tocci G . Implications of Guidelines for Hypertension Management in Europe. Circ Res. 2019; 124(7):972-974. DOI: 10.1161/CIRCRESAHA.119.314724. View

Azizi M, Schmieder R, Mahfoud F, Weber M, Daemen J, Davies J . Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial. Lancet. 2018; 391(10137):2335-2345. DOI: 10.1016/S0140-6736(18)31082-1. View

Mancia G, Zanchetti A, Bohm M, Christiaens T, Cifkova R, De Backer G . 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013; 34(28):2159-219. DOI: 10.1093/eurheartj/eht151. View

Volpe M, Gallo G, Tocci G . Is early and fast blood pressure control important in hypertension management?. Int J Cardiol. 2017; 254:328-332. DOI: 10.1016/j.ijcard.2017.12.026. View

Volpe M, Gallo G, Battistoni A, Tocci G . Highlights of ESC/ESH 2018 Guidelines on the Management of Hypertension: What Every Doctor Should Know. High Blood Press Cardiovasc Prev. 2019; 26(1):1-8. DOI: 10.1007/s40292-018-00297-y. View

Mahfoud F, Azizi M, Ewen S, Pathak A, Ukena C, Blankestijn P . Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies. Eur Heart J. 2020; 41(16):1588-1599. PMC: 7174031. DOI: 10.1093/eurheartj/ehaa121. View

Whelton P, Carey R, Aronow W, Casey Jr D, Collins K, Himmelfarb C . 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on.... Hypertension. 2017; 71(6):e13-e115. DOI: 10.1161/HYP.0000000000000065. View

Rader F, Kirtane A, Wang Y, Daemen J, Lurz P, Sayer J . Durability of blood pressure reduction after ultrasound renal denervation: three-year follow-up of the treatment arm of the randomised RADIANCE-HTN SOLO trial. EuroIntervention. 2022; 18(8):e677-e685. PMC: 10241283. DOI: 10.4244/EIJ-D-22-00305. View

Mahfoud F, Kandzari D, Kario K, Townsend R, Weber M, Schmieder R . Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial. Lancet. 2022; 399(10333):1401-1410. DOI: 10.1016/S0140-6736(22)00455-X. View

10.

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M . 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39(33):3021-3104. DOI: 10.1093/eurheartj/ehy339. View

11.

Volpe M, Patrono C . The key role of blood pressure lowering in cardiovascular prevention irrespective of baseline blood pressure and risk profile. Eur Heart J. 2021; 42(29):2814-2815. DOI: 10.1093/eurheartj/ehab320. View